Flu vaccine tied to lower Alzheimer's disease risk in older adults

Flu vaccine tied to lower alzheimer disease risk in older adults

Influenza vaccination is associated with a reduced Alzheimer disease (AD) risk among older U.S. adults, according to a study published online June 13 in the Journal of Alzheimer's Disease.

Avram S. Bukhbinder, M.D., from the John P. and Katherine G. McGovern Medical School at UTHealth in Houston, and colleagues used deidentified claims data (Sept. 1, 2009, through Aug. 31, 2019) to compare the risk for incident AD between (aged 65 years and older) with and without prior (935,887 flu-vaccinated and flu-unvaccinated matched pairs).

The researchers found that 5.1 percent of the flu-vaccinated patients and 8.5 percent of the flu-unvaccinated patients developed AD during a median follow-up of 46 months. The relative risk was 0.60 and the absolute risk reduction was 0.034, corresponding to a number needed to treat of 29.4.

"Since there is evidence that several vaccines may protect from Alzheimer's disease, we are thinking that it isn't a specific effect of the flu vaccine. Instead, we believe that the immune system is complex, and some alterations, such as pneumonia, may activate it in a way that makes Alzheimer's disease worse. But other things that activate the immune system may do so in a different way—one that protects from Alzheimer's disease," a coauthor said in a statement. "Clearly, we have more to learn about how the worsens or improves outcomes in this disease."

One author disclosed financial ties to Lilly, Acadia, and Biogen.


Explore further

Study: Flu vaccination linked to 40% reduced risk of Alzheimer's disease

More information: Abstract/Full Text
Journal information: Journal of Alzheimer's Disease

Copyright © 2022 HealthDay. All rights reserved.

Citation: Flu vaccine tied to lower Alzheimer's disease risk in older adults (2022, July 27) retrieved 25 September 2022 from https://medicalxpress.com/news/2022-07-flu-vaccine-tied-alzheimer-disease.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors